Exercise Intervention in Primary Open-angle Glaucoma
EYE-FIT
Impact of Physical Activity as a Coadjuvant Strategy to Pharmacological Treatment for Glaucoma Management: A Randomized Clinical Trial in Primary Open-angle Glaucoma Patients (EYE-FIT)
1 other identifier
interventional
136
1 country
1
Brief Summary
EYE-FIT is a randomized clinical trial with a two-arm parallel design aimed at assessing the impact of performing a structured and supervised physical training program on the different variables associated with glaucoma progression in pharmacologically treated primary open angle glaucoma patients. This intervention will include a supervised 24-weeks concurrent (endurance + resistance) training program comparing its influence to the standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2022
CompletedFirst Posted
Study publicly available on registry
January 30, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 30, 2023
January 1, 2023
1.9 years
December 30, 2022
January 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from baseline glaucomatous damage in the retina at 6 months
Optical coherence tomography for the assessment of glaucomatous damage in the macula and optic nerve head
Baseline (week 0) and after-intervention (week 25)
Change from baseline visual fields at 6 months
Evaluation of the visual fields with the Humphrey Field Analyzer using the Swedish Interactive Thresholding Algorithm (24-2) SITA-Standard protocol .
Baseline (week 0) and after-intervention (week 25)
Changes from baseline anterior eye morphology and corneal biomechanics at 6 months
Assessment of the anterior chamber morphology using the Pentacam Scheimpflug camera and the biomechanics of the cornea using the Corvis ST.
Baseline (week 0) and after-intervention (week 25)
Change from baseline electrophysiological activity in the retina at 6 months
Examination of the functional state of the retina with the photopic negative response and pattern ERG
Baseline (week 0) and after-intervention (week 25)
Change from baseline intraocular pressure at 6 months
Assessment of intraocular pressure levels
Baseline (week 0) and after-intervention (week 25)
Change from baseline ocular perfusion pressure at 6 months
Indirect calculation of ocular perfusion pressure by the measure of intraocular pressure and blood pressure
Baseline (week 0) and after-intervention (week 25)
Secondary Outcomes (13)
Self-reported vision-targeted health status
Baseline (week 0) and after-intervention (week 25)
Glaucoma-specific questionnaire
Baseline (week 0) and after-intervention (week 25)
Glaucoma-related quality of life
Baseline (week 0) and after-intervention (week 25)
Health-related quality of life
Baseline (week 0) and after-intervention (week 25)
Self-rated health in mobility, self-care, usual activities, pain/discomfort and anxiety/depression
Baseline (week 0) and after-intervention (week 25)
- +8 more secondary outcomes
Study Arms (2)
exercise
EXPERIMENTALThe intervention (endurance + resistance training) group will perform 48 training sessions (24 weeks, twice per week). In each session, they will perform the leg and arm cycling exercises during the first half of the session (15 minutes of leg cycling and 15 minutes of arm cycling) and resistance training exercises involving the lower-body (e.g., squat) and upper-body (e.g., a variety exercises performed against the resistance imposed by elastic bands) during the second half of the session.
control
NO INTERVENTIONThe control group will not perform any supervised training program, and will follow standard care.
Interventions
Eligibility Criteria
You may qualify if:
- Have an age between 50 and 70 years old
- No have undergone any surgical intervention for glaucoma treatment
- Be medically treated with prostaglandin analogues or with a combination of prostaglandin analogue and beta-blockers
You may not qualify if:
- Have an scheduled surgery for the following 6 months
- Have a sufficient level of mobility to perform supervised physical exercise
- Suffer any disease that prevent the practice of physical exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Granadalead
- University Hospital Virgen de las Nievescollaborator
- Durham Universitycollaborator
- University of Szczecincollaborator
Study Sites (1)
University of Granada
Granada, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- The assessment of the outcomes will be performed by researchers blinded to the group allocation of each participant.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 30, 2022
First Posted
January 30, 2023
Study Start
February 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
January 30, 2023
Record last verified: 2023-01